FI52339C - Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.

Info

Publication number
FI52339C
FI52339C FI703213A FI321370A FI52339C FI 52339 C FI52339 C FI 52339C FI 703213 A FI703213 A FI 703213A FI 321370 A FI321370 A FI 321370A FI 52339 C FI52339 C FI 52339C
Authority
FI
Finland
Prior art keywords
therapeutically active
dihydropyridine derivatives
preparing therapeutically
preparing
dihydropyridine
Prior art date
Application number
FI703213A
Other languages
English (en)
Swedish (sv)
Other versions
FI52339B (fi
Inventor
Friedrich Bossert
Wulf Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of FI52339B publication Critical patent/FI52339B/fi
Publication of FI52339C publication Critical patent/FI52339C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI703213A 1969-12-17 1970-11-30 Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi. FI52339C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691963188 DE1963188A1 (de) 1969-12-17 1969-12-17 Neue Cyanphenyl-1,4-dihydropyridinderivate

Publications (2)

Publication Number Publication Date
FI52339B FI52339B (fi) 1977-05-02
FI52339C true FI52339C (fi) 1977-08-10

Family

ID=5754097

Family Applications (1)

Application Number Title Priority Date Filing Date
FI703213A FI52339C (fi) 1969-12-17 1970-11-30 Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.

Country Status (19)

Country Link
US (2) US3691177A (fi)
JP (1) JPS4811102B1 (fi)
AT (1) AT301545B (fi)
BE (1) BE760483A (fi)
CA (1) CA928713A (fi)
CH (1) CH559178A5 (fi)
CS (1) CS157115B2 (fi)
DE (1) DE1963188A1 (fi)
DK (1) DK127113B (fi)
ES (1) ES386565A1 (fi)
FI (1) FI52339C (fi)
FR (1) FR2081373B1 (fi)
GB (1) GB1305794A (fi)
IE (1) IE34742B1 (fi)
IL (1) IL35678A (fi)
NL (1) NL171052C (fi)
NO (1) NO132590C (fi)
SE (1) SE364709B (fi)
ZA (1) ZA707820B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3996234A (en) * 1972-04-18 1976-12-07 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (en) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. 1,4-dihydropyridine derivatives useful against tumour cells
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
DE59410255D1 (de) * 1993-12-10 2003-04-17 Bayer Ag Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
FI3511319T3 (fi) 2014-07-03 2023-07-20 Celgene Quanticel Res Inc Lysiinispesifisen demetylaasi-1:n inhibiittoreita

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325505A (en) * 1965-02-24 1967-06-13 Smith Kline French Lab 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
US3511847A (en) * 1967-02-07 1970-05-12 Smithkline Corp 2,6-di-lower alkyl - 1,4-dihydro - 4-(2-trifluoromethylphenyl) - 3,5 - pyridinedicarboxylic acid esters
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern

Also Published As

Publication number Publication date
CS157115B2 (fi) 1974-08-23
IL35678A (en) 1974-07-31
NO132590B (fi) 1975-08-25
US3691177A (en) 1972-09-12
JPS4811102B1 (fi) 1973-04-10
NL7018070A (fi) 1971-06-21
US3764683A (en) 1973-10-09
NL171052C (nl) 1983-02-01
AT301545B (de) 1972-09-11
NO132590C (fi) 1975-12-03
FI52339B (fi) 1977-05-02
FR2081373B1 (fi) 1975-04-18
IE34742B1 (en) 1975-08-06
NL171052B (nl) 1982-09-01
SE364709B (fi) 1974-03-04
CH559178A5 (fi) 1975-02-28
FR2081373A1 (fi) 1971-12-03
CA928713A (en) 1973-06-19
ZA707820B (en) 1971-08-25
IE34742L (en) 1971-06-17
ES386565A1 (es) 1973-03-16
DK127113B (da) 1973-09-24
DE1963188A1 (de) 1971-06-24
BE760483A (fr) 1971-06-17
IL35678A0 (en) 1971-01-28
GB1305794A (fi) 1973-02-07

Similar Documents

Publication Publication Date Title
FI49300C (fi) Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.
FI52078C (fi) Menetelmä N-alkyyli-1,4-dihydro-pyridiinien valmistamiseksi.
FI52466C (fi) Menetelmä terapeuttisesti käytettävän S-adenosyyli-L-metioniinin tri-p -tolueenisulfonaatin valmistamiseksi.
FI51190C (fi) Menetelmä terapeuttisesti vaikuttavien, erityisesti koronadilatooriste n N-(3,4,5-trimetoksi-kinnamoyyli)-piperatsiinijohdannaisten valmistam iseksi.
FI52339C (fi) Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.
NO140161C (no) Plantemaskin.
FI51936C (fi) Menetelmä terapeuttisesti käytettävien 3,4-dihydronaftalenonioksi-2-hy droksipropyyliamiinien ja näiden happo-additiosuolojen valmistamiseksi .
FI49034C (fi) Menetelmä terapeuttisesti vaikuttavan 3,4-dihydroisokinoliinijohdannai sen valmistamiseksi.
DK136421B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridin-derivater.
NL7514498A (nl) Landbouwmachine.
FI52349C (fi) Menetelmä uusien terapeuttisesti käytettävien 2beta,16beta-piperidino- 5alfa-androstaanien valmistamiseksi.
OA03019A (fr) Procédé de préparation du 2,2'(éthylènediimino)-di-1-butanol destrogyre.
NL7506544A (nl) 1,4-benzopyron-6-carbonzuurderivaten.
FI51479C (fi) Menetelmä terapeuttisesti käytettävän 3,3-disubstituoidun heksahydro-1 H-atsepiiniyhdisteen valmistamiseksi.
FI50333C (fi) Tapa valmistaa terapeuttisesti aktiivista levo-1-n-butyyli-2',6'-pipek oloksylididiä.
NL7601520A (nl) Smeedmachine.
FI51342C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien hydroksifenyylialkyylia miinijohdannaisten valmistamiseksi.
FI45975C (fi) Menetelmä terapeuttisesti käytettävän 1,2,3,6,7,11b-heksahydro-4H-pyra tsino-/2,1-a/-isokinoliinin valmistamiseksi.
FI50420C (fi) Menetelmä terapeuttisesti aktiivisten 4-pyrimidinyyli-1,4-dihydropyrid iinijohdannaisten valmistamiseksi
FI49413C (fi) Menetelmä uusien terapeuttisesti vaikuttavien fentiatsiinijohdannaisie n valmistamiseksi.
FI52096C (fi) Menetelmä analgeettisesti aktiivisten 2,3-dihydrotiatsolo(3.2.a)pyrimi diini-5-onien valmistamiseksi
FI51349C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi.
FI50630C (fi) Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi.
SE418084B (sv) Forfarande for framstellning av 1,2,4-bensotiadiazin-derivat
FI49291C (fi) Menetelmä lääkeaineena aktiivisen halogeenisubstituoidun 2,6-ksylididi n valmistamiseksi.